Key result
The Chester Step Test demonstrated that participants who developed more severe Acute Mountain Sickness were able to exercise for longer than those with mild symptoms (p=0.004).
Why the study?
Does the Chester Step Test predict susceptibility to Acute Mountain Sickness in mountaineers?
Observational (n=8)
No
Does the Chester Step Test predict susceptibility to Acute Mountain Sickness in mountaineers?
p-value: p=0.004
The Chester Step Test may be a useful field tool to predict susceptibility to severe Acute Mountain Sickness based on aerobic capacity and heart rate response at altitude.
May link higher fitness to severe AMS risk; leaves open Chester Step Test utility pending prospective validation.
Introduction We undertook an observational study with eight volunteer participants which aimed to identify whether simple cardio-respiratory measurements, before and after different forms of exercise testing, could offer a reliable means of predicting Acute Mountain Sickness (AMS). Three tests were used, all of which were easily performed in the mountain environment. Methods During an expedition to Mt Elbrus (5642m), in the Caucasus region of Russia, daily cardiorespiratory observations were made on eight subjects after exercise testing, and compared with Lake Louise Self-Assessment Questionnaire (LLSAQ) scores. Results At all altitudes, the Chester Step Test (CST) demonstrated differences in the time taken to reach 80% of the calculated maximum heart rate between participants due to variance in levels of aerobic fitness. At 3800m, there was a significant difference (t = 3.06, p = 0.02) between those who reached 80% of their maximum heart rate rapidly, and those who did not. This difference was associated with symptoms of severe AMS; the group who developed more severe symptoms were able to exercise for longer than the group who demonstrated mild AMS (Mann-Whitney U score: p = 0.004). Conclusions Despite small numbers, these results suggest that there is a difference between mountaineers who develop severe AMS and those who are less severely affected, upon testing of their aerobic capacity. This may reflect adaptation of the cardiovascular system, and further investigation is warranted.
No takes yet. Share an insight, caveat, or question.
Thornton et al. (2017) conducted an observational in Acute Mountain Sickness (AMS) (n=8). Chester Step Test (CST) was evaluated on Time taken to reach 80% of calculated maximum heart rate and association with severe AMS (p=0.004). The Chester Step Test demonstrated that participants who developed more severe Acute Mountain Sickness were able to exercise for longer than those with mild symptoms (p=0.004).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: